Secular trends in prescription patterns of single-pill combinations of an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker plus a thiazide diuretic for hypertensive patients in Taiwan

Acta Cardiologica Sinica

Volumn 29, Issue 1, 2013, Pages 49-55

  Hsu, Chih Neng ^a   Wang, Tzung Dau ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Angiotensin receptor blocker; Angiotensin converting enzyme inhibitor; Diuretic; Hypertension; Single pill combinations

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; HYPERTENSION; MALE; MEDICAL RECORD REVIEW; NATIONAL HEALTH INSURANCE; PHYSICIAN; PRESCRIPTION; REIMBURSEMENT; REVIEW; TAIWAN; TREND STUDY;

EID: 84874594422     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Whelton PK, Beevers DG, Sonkodi S. Strategies for improvement of awareness, treatment and control of hypertension: results of a panel discussion. J Hum Hypertens 2004;18:563-5.
2. Centers for Disease Control and Prevention. Vital signs: prevalence, treatment, and control of hypertension?United States, 1999-2002 and 2005-2008.MMWRMorb Mortal Wkly Rep 2011; 60:103-8.
3. ESH/ESC Hypertension Practice Guidelines Committee. 2007 Guidelines for the Management of Arterial Hypertension. J Hypertens 2007;25:1105-87.
4. Chiang CE,Wang TD, Li YH, et al. Hypertension Committee of the Taiwan Society of Cardiology. J Formos Med Assoc 2010;109: 740-73.
5. Ezzati M, Lopez AD, Rodgers A, et al. Selected major risk factors and global and regional burden of disease. Lancet 2002;360: 1347-60.
6. Wong ND, Lopez VA, L'Italien G, et al. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med 2007;167:2431-6.
7. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. J AmMed Assoc 2010;303:2043-50.
8. Elliott WJ. The economic impact of hypertension. J Clin Hypertens 2003;5:3-13.
9. Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treat-ment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-7.
10. Sharma AM, Wittchen HU, Kirch W, et al. High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens 2004;22:479-86.
11. Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: a metaanalysis. Am J Med 2007;120:713-9.
12. Liu PH, Wang JD. Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan. BMC Health Services Research 2008;8:133-43.
13. World Health Organization.World Health Statistics 2012. http://www.who.int/healthinfo/EN-WHS2012-Full.pdf (accessed on Oct 23, 2012).
14. National Institute for Health and Clinical Excellence. The clinical management of primary hypertension in adults. http://publications. nice.org.uk/hypertension-cg127 (accessed on Oct. 24, 2012).
15. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992; 304:405-12.
16. Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906.
17. Medical Research CouncilWorking Party.MRC trial of treatment of mild hypertension: principal results. BMJ 1985;291:97-104.
18. Zanchetti A, Bond MG, Hennig M, et al. European Lacidipine Study on Atherosclerosis investigators. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation 2002;106:2422-7.
19. Fuller RW, Choudry NB. Increased cough reflex associated with angiotensin converting enzyme inhibitor cough. BMJ 1987;24: 1025-6.
20. Woo J, Chan TY. A high incidence of cough associated with combination therapy of hypertension with isradipine and lisinopril in Chinese subjects. Br J Clin Pract 1991;45:178-80.
21. Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol 1995;40:141-4.
22. Spinar J, Vitovec J, Soucek M, et al. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers. Vnitrni Lekarstvi 2009;55:481-8.
23. Yusuf S, Teo K, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358:1547-59.
24. Benford M, Milligan G, Pike J, et al. Fixed-dose combination antidiabetic therapy: real-world factors associated with prescribing choices and relationship with patient satisfaction and compliance. Adv Ther 2012;29:26-40.